| News
September 3, 2008 Chief Resident, Marka Crittenden, was selected to present her original work at the 2008 Translational Advances in Radiation Oncology and Cancer Imaging Symposium
Chief Resident & Holman Pathway Research Pathway Resident, Marka Crittenden, MD, PhD, has been selected to present her original work titled "Enhanced Tumor Therapy by Combining SBRT with Immune Adjuvant anti-CD134 Antibody", at the 2008 Translational Advances in Radiation Oncology and Cancer Imaging Symposium taking place October 17-18, 2008 at the Westin Arlington Gateway, Arlington, Virginia.
 Acceptance Letter from Translational Advances Symposium
|
|
